There is a shortage of 10 crucial HIV/Aids drugs as a result of Covid-19 pandemic, the UN has warned.
In a latest report by UNAids, at least 10 anti-retroviral therapy (ART) medication is in short supply.
They include Tenofovir, Abacavuir, Cotrimoxazole suspension, Ritonavir tablets, Nevirapine suspension (for new born), Zidovudine solution, Zidovudine/lamivudine (AZT/3TC), Lopinavir/ Ritonavir(LPV/r) 100/25 mg, and LPV/r pellets 40/10 formulation.
A model by the World Health Organisation and the Joint United Nations Programmes on HIV and Aids (UNAids) estimated a six-month disruption of antiretroviral therapy could lead to more than 500 000 additional Aids-related deaths, including from tuberculosis, in sub-Saharan Africa in 2020–2021.
READ MORE
Scientists urge nations to prepare for pandemic by voting wisely
Health Ministry set to roll out new HIV testing model in July
In Kenya, persons living with HIV have already confirmed a short supply of Cotrimoxazole, which is sold as Septrin.